Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial - Claudine Duvivier, Jade Ghosn, Cathia Soulié, Gilles Peytavin, M. A. Genin, Michèle Algarté Génin, Jean-Michel Molina, Christine Katlama, Lambert Assoumou, Vincent Calvez, Olivier Bouchaud, Dominique Costagliola, Marie Essig - Dissemin

Language
Login

Published in

Oxford University Press, Journal of Antimicrobial Chemotherapy, 4(62), p. 797-808, 2008

DOI: 10.1093/jac/dkn278

Links

Tools

Export citation

Search in Google Scholar

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial

Journal article published in 2008 by Claudine Duvivier, Jade Ghosn, Cathia Soulié, Gilles Peytavin, M. A. Genin, Michèle Algarté Génin, Jean-Michel Molina, Christine Katlama, Lambert Assoumou, Vincent Calvez, Olivier Bouchaud, Dominique Costagliola, Marie Essig

ORCID

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO